1,424
Views
10
CrossRef citations to date
0
Altmetric
Short Communication

Peptidomimetic ethyl propenoate covalent inhibitors of the enterovirus 71 3C protease: a P2–P4 study

, , , , , , , , , , , & show all
Pages 332-339 | Received 03 Jan 2015, Accepted 02 Feb 2015, Published online: 20 Mar 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Hyemin Lee, Eun Ah Shin, Jae Hee Lee, Deoksoo Ahn, Chang Geun Kim, Ju-Ha Kim & Sung-Hoon Kim. (2018) Caspase inhibitors: a review of recently patented compounds (2013-2015). Expert Opinion on Therapeutic Patents 28:1, pages 47-59.
Read now

Articles from other publishers (9)

Shuqi Wang, Zehan Pang, Huahao Fan & Yigang Tong. (2023) Advances in anti-EV-A71 drug development research. Journal of Advanced Research.
Crossref
Subramanyam Vankadara, Monique Danielle Dawson, Jia Yi Fong, Qin Yao Oh, Qi An Ang, Boping Liu, Hong Yun Chang, Judice Koh, Xiaoying Koh, Qian Wen Tan, Joma Joy & Cheng San Brian Chia. (2022) A Warhead Substitution Study on the Coronavirus Main Protease Inhibitor Nirmatrelvir. ACS Medicinal Chemistry Letters 13:8, pages 1345-1350.
Crossref
Debarati Ghosh, Karan Sehgal, Babasaheb Sodnar, Nikhil Bhosale, Deepaneeta Sarmah, Aishika Datta, Antra Chaudhary, Kiran Kalia, Xin Wang & Pallab Bhattacharya. (2022) Drug repurposing for stroke intervention. Drug Discovery Today 27:7, pages 1974-1982.
Crossref
A. S. Volobueva, V. V. Zarubaev & K. S. Lantseva. (2021) Development of antiviral therapeutics combating coxsackievirus type B3 infection. Russian Journal of Infection and Immunity 11:1, pages 57-67.
Crossref
Sako Mirzaie, Fatemeh Abdi, Amin GhavamiNejad, Brian Lu & Xiao Yu Wu. 2021. Antiviral Drug Discovery and Development. Antiviral Drug Discovery and Development 285 312 .
Yixuan Wang, Huiqiang Wang, Xinbei Jiang, Zhi Jiang, Tingting Guo, Xingyue Ji, Yanping Li, Yuhuan Li & Zhuorong Li. (2019) Synthesis and Broad Antiviral Activity of Novel 2-aryl-isoindolin-1-ones towards Diverse Enterovirus A71 Clinical Isolates. Molecules 24:5, pages 985.
Crossref
Quandeng Nie, Xiaoyi Xu, Qi Zhang, Yuying Ma, Zheng Yin & Luqing Shang. (2018) 3D-quantitative structure-activity relationship study for the design of novel enterovirus A71 3C protease inhibitors. Chemical Biology & Drug Design 92:4, pages 1750-1762.
Crossref
Guang-Hui Ma, Yan Ye, Dan Zhang, Xin Xu, Pei Si, Jian-Long Peng, Yong-Long Xiao, Rui-Yuan Cao, Yu-Ling Yin, Jing Chen, Lin-Xiang Zhao, Yu Zhou, Wu Zhong, Hong Liu, Xiao-Min Luo, Li-Li Chen & Xu Shen. (2016) Identification and biochemical characterization of DC07090 as a novel potent small molecule inhibitor against human enterovirus 71 3C protease by structure-based virtual screening. European Journal of Medicinal Chemistry 124, pages 981-991.
Crossref
Yong Wah Tan, Melgious Jin Yan Ang, Qiu Ying Lau, Anders Poulsen, Fui Mee Ng, Siew Wen Then, Jianhe Peng, Jeffrey Hill, Wan Jin Hong, Cheng San Brian Chia & Justin Jang Hann Chu. (2016) Antiviral activities of peptide-based covalent inhibitors of the Enterovirus 71 3C protease. Scientific Reports 6:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.